(1) Whether Court of Appeals conclusion, that Rogero had not established by a preponderance of the evidence between his encephalopathy and his DTaP vaccination, is in accordance with 42 U.S.C. § 300aa-13(a)(1)(A) and The Rehabilitation Act, when the Court published findings from preponderance evidence, every required matter of § 300aa-11(c)(1)?

(2) Whether Federal Circuit contravened § 300aa-13(a)(1)(B) as interpreted by this Court in Shalala v. Whitecotton, subsequently violating The Rehabilitation Act, Section 504?

Whether the child's encephalopathy was caused by his DTaP vaccination and entitled to compensation under the National Vaccine Injury Compensation Program